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Background:  
Waldenström macroglobulinemia (WM) is an indolent (slow-growing) subtype of non-Hodgkin 
lymphoma that affects small lymphocytes. The risk of WM increases with age with median age at 
diagnosis of 63 years.  Men are more likely than women to develop the WM. The overall incidence of 
WM is approximately five cases per one million persons per year 
Case presentation:  
Many patients have constitutional symptoms (fevers, night sweats, weight loss), but some patients can 
be asymptomatic even for several years. WM is characterized by over production of monoclonal IgM 
and in some cases increased IgM can result in hyperviscosity syndrome (HVS). HVS  refers to an 
increase in serum viscosity secondary to circulating proteins and results in a variety of symptoms like 
visual symptoms, altered mental status, stroke or congestive heart failure. The diagnosis is made by 
clinical and laboratory findings, like increased serum protein levels and increased serum viscosity. The 
patient should receive prompt therapy  to avoid progression to multisystem organ failure and prevent 
life-threatening complications. We report a case of a 51-year-old man with a 4-year history of 
increased IgM and untreated WM who presented  with HVS.  His plasma viscosity was 10.94 mPa.s. 
He underwent diagnostic workup and was finally diagnosed with WM ISS 1. 
Conclusion:  
Even though Waldenstrom macroglobulinemia is a rare disease and can be asymptomatic for several 
years, and can present with a variety of symptoms, it should always be considered as a possible 
differential diagnosis in patients with increased IgM and treated properly.  
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